InChI=1S/C5H10N2O3/c6-3(5(9)10)1-2-4(7)8/h3H,1-2,6H2,(H2,7,8)(H,9,10)/t3-/m0/s1 |
ZDXPYRJPNDTMRX-VKHMYHEASA-N |
|
Mus musculus
(NCBI:txid10090)
|
Source: BioModels - MODEL1507180067
See:
PubMed
|
Chlamydomonas reinhardtii
(NCBI:txid3055)
|
See:
PubMed
|
Saccharomyces cerevisiae
(NCBI:txid4932)
|
Source: yeast.sf.net
See:
PubMed
|
Escherichia coli
(NCBI:txid562)
|
See:
PubMed
|
Homo sapiens
(NCBI:txid9606)
|
See:
DOI
|
Bronsted base
A molecular entity capable of accepting a hydron from a donor (Bronsted acid).
(via organic amino compound )
Bronsted acid
A molecular entity capable of donating a hydron to an acceptor (Bronsted base).
(via oxoacid )
|
|
Escherichia coli metabolite
Any bacterial metabolite produced during a metabolic reaction in Escherichia coli.
Saccharomyces cerevisiae metabolite
Any fungal metabolite produced during a metabolic reaction in Baker's yeast (Saccharomyces cerevisiae ).
micronutrient
Any nutrient required in small quantities by organisms throughout their life in order to orchestrate a range of physiological functions.
human metabolite
Any mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens).
EC 1.14.13.39 (nitric oxide synthase) inhibitor
An EC 1.14.13.* (oxidoreductase acting on paired donors, incorporating 1 atom of oxygen, with NADH or NADPH as one donor) inhibitor that interferes with the action of nitric oxide synthase (EC 1.14.13.39).
mouse metabolite
Any mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus).
fundamental metabolite
Any metabolite produced by all living cells.
(via glutamine )
|
|
nutraceutical
A product in capsule, tablet or liquid form that provide essential nutrients, such as a vitamin, an essential mineral, a protein, an herb, or similar nutritional substance.
|
|
View more via ChEBI Ontology
(2S)-2,5-diamino-5-oxopentanoic acid
|
IUPAC
|
(2S)-2-amino-4-carbamoylbutanoic acid
|
JCBN
|
(S)-2,5-diamino-5-oxopentanoic acid
|
ChEBI
|
Glutamic acid 5-amide
|
HMDB
|
Glutamic acid amide
|
HMDB
|
GLUTAMINE
|
PDBeChem
|
L-(+)-glutamine
|
ChemIDplus
|
L-2-Aminoglutaramic acid
|
KEGG COMPOUND
|
L-2-aminoglutaramic acid
|
ChEBI
|
L-2-aminoglutaramic acid
|
DrugBank
|
L-glutamic acid γ-amide
|
NIST Chemistry WebBook
|
L-Glutamin
|
ChEBI
|
L-Glutamine
|
KEGG COMPOUND
|
L-Glutaminsäure-5-amid
|
ChEBI
|
Levoglutamide
|
KEGG DRUG
|
Q
|
ChEBI
|
1311
|
DrugCentral
|
C00001359
|
KNApSAcK
|
C00064
|
KEGG COMPOUND
|
D00015
|
KEGG DRUG
|
DB00130
|
DrugBank
|
ECMDB00641
|
ECMDB
|
GLN
|
MetaCyc
|
GLN
|
PDBeChem
|
Glutamine
|
Wikipedia
|
HMDB0000641
|
HMDB
|
LSM-4741
|
LINCS
|
YMDB00002
|
YMDB
|
View more database links |
1723797
|
Beilstein Registry Number
|
ChemIDplus
|
1723797
|
Reaxys Registry Number
|
Reaxys
|
3509
|
Gmelin Registry Number
|
Gmelin
|
56-85-9
|
CAS Registry Number
|
KEGG COMPOUND
|
56-85-9
|
CAS Registry Number
|
NIST Chemistry WebBook
|
56-85-9
|
CAS Registry Number
|
ChemIDplus
|
11139387
|
PubMed citation
|
Europe PMC
|
15204730
|
PubMed citation
|
Europe PMC
|
22055478
|
PubMed citation
|
Europe PMC
|
22206385
|
PubMed citation
|
Europe PMC
|
22451274
|
PubMed citation
|
Europe PMC
|
22453904
|
PubMed citation
|
Europe PMC
|
22575040
|
PubMed citation
|
Europe PMC
|
22770225
|
PubMed citation
|
Europe PMC
|
29438107
|
PubMed citation
|
Europe PMC
|
|
|